Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandhya Appachu

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Indian Journal of Surgical Oncology|December 4, 2012
Systemic therapy in soft tissue sarcomas: past, present and futureSamit Purohit, Rohan Bhise, Sandhya Appachu, et al.
Ecancermedicalscience|September 7, 2013
A complex variant t(3;15) (q26;q13) representing cryptic/masked acute promyelocytic leukaemia with a novel breakpoint of chromosome 15-a case reportSandhya Appachu, Chintaparthi Obulareddy, Nagesh T Sirsath, et al.
Indian Journal of Cancer|March 9, 2026
Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experienceK S Sandeep, Sandhya Appachu, Ravi B Diwaker, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 10, 2014
Posterior reversible encephalopathy syndrome in pediatric acute leukemia: Case series and literature reviewM Sandhya Appachu, Samit Purohit, K C Lakshmaiah, et al.
Indian Journal of Surgical Oncology|December 19, 2025
Selective De-escalation of Axillary Surgery Post Neoadjuvant Chemotherapy in Breast Cancer-Are We Ready?Aishwarya Mohan, Kanyadhara Lohita Krishna, Sandhya Appachu, et al.
Advances in Hematology|December 1, 2015
Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-EffectivenessLinu A Jacob, S Aparna, K C Lakshmaiah, et al.
Chemotherapy Research and Practice|March 1, 2016
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South IndiaGovind Babu, Smitha Carol Saldanha, Lakshmaiah Kuntegowdanahalli Chinnagiriyappa, et al.
Translational Oncology|August 14, 2022
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancersAruna Korlimarla, Hari Ps, Jyoti Prabhu, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Indian Journal of Surgical Oncology|December 4, 2012
Systemic therapy in soft tissue sarcomas: past, present and futureSamit Purohit, Rohan Bhise, Sandhya Appachu, et al.
Ecancermedicalscience|September 7, 2013
A complex variant t(3;15) (q26;q13) representing cryptic/masked acute promyelocytic leukaemia with a novel breakpoint of chromosome 15-a case reportSandhya Appachu, Chintaparthi Obulareddy, Nagesh T Sirsath, et al.
Indian Journal of Cancer|March 9, 2026
Clinical outcomes and safety study of CDK4/6 inhibitors in hormone-positive metastatic breast cancer - A real-world tertiary cancer center experienceK S Sandeep, Sandhya Appachu, Ravi B Diwaker, et al.
Indian Journal of Medical and Paediatric Oncology : Official Journal of Indian Society of Medical & Paediatric Oncology|July 10, 2014
Posterior reversible encephalopathy syndrome in pediatric acute leukemia: Case series and literature reviewM Sandhya Appachu, Samit Purohit, K C Lakshmaiah, et al.
Indian Journal of Surgical Oncology|December 19, 2025
Selective De-escalation of Axillary Surgery Post Neoadjuvant Chemotherapy in Breast Cancer-Are We Ready?Aishwarya Mohan, Kanyadhara Lohita Krishna, Sandhya Appachu, et al.
Advances in Hematology|December 1, 2015
Decitabine Compared with Low-Dose Cytarabine for the Treatment of Older Patients with Newly Diagnosed Acute Myeloid Leukemia: A Pilot Study of Safety, Efficacy, and Cost-EffectivenessLinu A Jacob, S Aparna, K C Lakshmaiah, et al.
Chemotherapy Research and Practice|March 1, 2016
The Efficacy, Safety, and Cost Benefit of Olanzapine versus Aprepitant in Highly Emetogenic Chemotherapy: A Pilot Study from South IndiaGovind Babu, Smitha Carol Saldanha, Lakshmaiah Kuntegowdanahalli Chinnagiriyappa, et al.
Translational Oncology|August 14, 2022
Comprehensive characterization of immune landscape of Indian and Western triple negative breast cancersAruna Korlimarla, Hari Ps, Jyoti Prabhu, et al.
Pageof 1